- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $22.25M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $22.74M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $73.67M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $71.4M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $145.59M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $145.87M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $126.9M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $90.37M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $57.26M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $83.77M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $144.22M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $164.65M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 17.15M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $176K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$25.39M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.04 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$1.04 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $17.94M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$15.42M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$36.57M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $6M |